Aspetar, pharmacy college sign accord on clinical training
March 22 2016 11:44 PM
aspetar
Aspetar and QU representatives pose for a photo after signing the agreement.

Aspetar, the leading specialised orthopaedic and sports medicine hospital, and Qatar University’s College of Pharmacy (QU-CPH) recently inked a clinical training agreement to offer the use of the required training facilities for QU-CPH’s female students to fulfil their academic requirements.
Dr Mohamed Ghaith al-Kuwari, acting director-general of Aspetar, and Dr Ayman El-Kadi, dean of CPH, signed the agreement that would provide experiential activities and practical learning opportunities for the female students.
“This partnership between Aspetar and Qatar University’s College of Pharmacy forms an important dimension in the development of education in the field of sports medicine, providing an opportunity for students to develop their skills in clinical pharmacy in the field of sports medical care and preparation for medical coverage,” said Dr al-Kuwari.
“The QU College of Pharmacy is proud to partner with Aspetar in this important clinical training agreement. The new partnership builds on the commitment of QU-CPH to prepare our students in the use of pharmaceuticals in sports-related cases,” said Dr El-Kadi.
QU-CPH is the first and only pharmacy programme in Qatar and the only institution outside of Canada that is accredited by the Canadian Council for Accreditation of Pharmacy. The College of Pharmacy is accredited for both its bachelor and doctorate programmes and Aspetar will be affiliated as a partner in the practical training of both in Qatar, according to a statement.
Starting in June, Aspetar will function as a training location for QU-CPH students - enabling them to put their theoretical learning to practice. As part of the training programme within the Bachelor degree at QU-CPH, pharmacy students will now be able to complete one of the six required four-week clinical rotations at Aspetar hospital.



There are no comments.

LEAVE A COMMENT Your email address will not be published. Required fields are marked*
MORE NEWS